Latest News in the pharma Industry

Market News

Allergan launches first and only oral contraceptive softgel capsule

Allergan launches first and only oral contraceptive softgel capsule

10 Nov 2016

Taytulla 1 mg/20 mcg will provide women with a new and effective option.

Read more 
Saneca Pharma secures agreement to produce enteric-coated pellets for Menarini

Saneca Pharma secures agreement to produce enteric-coated pellets for Menarini

9 Nov 2016

CDMO to invest in its facility in Hlohovec, Slovakia, to increase the scale at which it can perform wurster coating of the pellets.

Read more 
Schizophrenia treatment urgently requires drugs targeting negative symptoms

Schizophrenia treatment urgently requires drugs targeting negative symptoms

9 Nov 2016

Currently, there is no available drug that can treat the negative symptoms of schizophrenia, according to GlobalData.

Read more 
Increased development of highly-targeted biologics set to change composition of asthma therapeutics market

Increased development of highly-targeted biologics set to change composition of asthma therapeutics market

9 Nov 2016

Biologics and monoclonal antibodies to become a bigger presence within the small-molecule-dominated landscape.

Read more 
Positive results for Alkermes’ Phase III study spell good news for major depressive disorder space

Positive results for Alkermes’ Phase III study spell good news for major depressive disorder space

8 Nov 2016

GlobalData anticipates ALKS-5461 will enter the US market in early 2018.

Read more 
Mylan and Biocon announce FDA submission for proposed biosimilar trastuzumab

Mylan and Biocon announce FDA submission for proposed biosimilar trastuzumab

8 Nov 2016

Potential to be first submission of a proposed biosimilar trastuzumab in the US.

Read more 
AdAlta licenses Alzheimer's disease-specific shark antibodies to Crossbeta Biosciences

AdAlta licenses Alzheimer's disease-specific shark antibodies to Crossbeta Biosciences

8 Nov 2016

These shark antibodies are considered to have immediate and highly disease-specific potential for the diagnosis and treatment of Alzheimer’s disease.

Read more 
Seward announces merger and restructuring plans to establish FermionX Ltd

Seward announces merger and restructuring plans to establish FermionX Ltd

7 Nov 2016

Merger with sister company, C-Tech Electronics Ltd, to form a new vertically integrated manufacturing company.

Read more 
SMC ‘yes’ to first immunotherapy combination for skin cancer patients

SMC ‘yes’ to first immunotherapy combination for skin cancer patients

7 Nov 2016

Allows adult patients with advanced melanoma to receive first-line treatment with the potentially life-extending combination therapy of Opdivo (nivolumab) and Yervoy (ipilimumab) on the NHS in Scotland.

Read more 
Merck invests €250 million in production value chain in China

Merck invests €250 million in production value chain in China

6 Nov 2016

Merck is the first multinational enterprise to dedicate a large-scale green-field investment (€170 million) to the production of pharmaceuticals on China’s Essential Drug List.

Read more 
Atriva Therapeutics received Notice of Allowance from USPTO

Atriva Therapeutics received Notice of Allowance from USPTO

6 Nov 2016

Patent will cover a method of treating a subject having a viral infection caused by an influenza virus with neuraminidase inhibitors in combination with MEK inhibitors.

Read more 
Breakthrough immunotherapy for blood cancer becomes available to UK patients

Breakthrough immunotherapy for blood cancer becomes available to UK patients

6 Nov 2016

First early access scheme for breakthrough immunotherapy in blood cancer.

Read more